CIBER Completes Commercial Software Redesign; Awarded New Contract From TeleTracking Technologies
PITTSBURGH, Aug. 7 /PRNewswire-FirstCall/ -- CIBER, Inc. (NYSE: CBR ) announced the completion of a 4-year, multi-million dollar re-architecture and redevelopment project with TeleTracking Technologies, Inc. CIBER has also been awarded a new contract to assist with the design and...AspireHR Completes Phase 1 SAP HR Initiative for Shire Pharmaceuticals
AspireHR and Shire Pharmaceuticals complete Phase 1 of their shared SAP human resources initiative. Wayne, PA (PRWEB) August 7, 2009 -- AspireHR, an SAP HR software, consulting, and SaaS company, is proud to announce the successful Go-Live of Phase 1 of their SAP HR ini...My1Stop.com Completes Upgrades to Prime Labels Offering and Easy Ordering Page Design
My1Stop.com extended its commitment to being the leading online - and offline - provider of prime labels with new site enhancements. The site enhancements provide customers with a much more intuitive approach to pricing and ordering prime labels from the site. Ft. Scott...Nephros, Inc. Completes $1.25 Million Private Placement
RIVER EDGE, N.J., July 30 /PRNewswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that it has completed a private placement...Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
SAN DIEGO, July 24 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) ("Cardium") today announced that it has completed the asset sale of Cardium's InnerCool Therapies business ("InnerCool") to Royal Philips Electronics (NYSE: PHG , AEX: PHI). The asset purch...Genstar Capital Portfolio Company Univita Health Completes Debt Financing
SAN FRANCISCO, July 22 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the industrial technology, life sciences, healthcare services, business services and software services industries, today announced that its...Nuvilex Completes First Sale of Last Shot Hangover Remedy(TM)
CHERRY HILL, N.J., July 15 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), announced today that it completed its first sale of its Last Shot Hangover Remedy. The sale, a 36 shot case of Last Shot Hangover Remedy(TM), was made to a local bar e...meridianEMR Completes Surescripts(R) Certification
LIVINGSTON, N.J., July 14 /PRNewswire/ -- meridianEMR, a leading provider of electronic medical records systems, electronic prescribing and advanced healthcare analytics, announced today that it has completed certification with Surescripts on June 24(th), 2009. meridianEMR user...Hard To Treat Diseases (HTDS.PK) Completes India Order
SHENZHEN, China, July 10 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) www.htdsmedical.com - announced today that the second batch of Hepatitis A Vaccine of 2009 was delivered to India, by the company. This is the second completed batch exported to India this year by the company. T...SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
MUMBAI, India, Aug. 5 /PRNewswire/ -- SIRO Clinpharm, a global, full service Contract Research Organization (CRO) founded in India, today announced the successful completion of the implementation phase of the Oracle Life Science Application Suite (OLSAS) by going live with Oracle S...R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
TOKYO, July 21 /PRNewswire/ -- R-Tech Ueno, Ltd. announced on July 17 that as a phase 1 clinical study on the new compound RK-023 that is being developed by our company as a therapeutic drug of androgenetic alopecia (male pattern baldness; see the note below) has been completed. The ...Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
First-In-Class Human Collagen Technology Used in Cranial Surgical Procedures EATONTOWN, N.J., June 10 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic products for regenerative healing, announced today that it has completed enrollment for...Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
Completion of enrollment keeps Company on track to report primary study results in third quarter of this year ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today that enrollment has been completed in the second Phase II clinical trial of its trival...QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
Primary Endpoints Met; Data Demonstrate MoxDuo(TM) IR Provides Better Tolerability Than Morphine and Oxycodone Alone SYDNEY, Australia and BEDMINSTER, N.J., April 20 /PRNewswire-FirstCall/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the successful completion of a Phase 3 ...Major Restless Legs Study Completes Enrollment With Support From MediciGlobal
KING OF PRUSSIA, Pa., March 31 /PRNewswire/ -- Successful and seamless completion of clinical trial enrollment requires careful forecasting of screened to randomized patients, market research, an effective recruitment strategy, and project management guided by real time metrics. MediciGlobal...Large Power Battery/Electric Reciprocating Saw
Description:... The 7700 Reciprocating Saw completes the large power system with our simple twist-lock blade hub and selection of saw blades....Roche OMNI S Blood Gas Analyzer
Description:... Roche OMNI S is the next generation Critical Care Analyzer completes and extends the Roche product portfolio for Hospital Point of Care applications. The modular concept allows to customize the comprehensive parameter m...SOMATOM Sensation Cardiac 64-Slice CT Scanner
Description:... which facilitates a complete examination within 10 minutes from scan to diagnosis.* A comprehensive portfolio of leading cardiovascular applications completes the SOMATOM Sensation Cardiac 64 as the ultimate cardiac CT solution....DOE Joint Genome Institute completes soybean genome
WALNUT CREEK, Calif. The U.S. Department of Energy Joint Genome Institute (DOE JGI) has released a complete draft assembly of the soybean (Glycine max) genetic code, making it widely available to the research community to advance new breeding strategies for one of the world's most valuable plant c...L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
STAMFORD, Conn., Aug. 14 /PRNewswire-FirstCall/ -- L-1 Identity Solutions, Inc. (NYSE: ID ), a leading provider of identity solutions and services, today announced that it closed its tender offer for all of the outstanding shares of Digimarc Corporation (Nasdaq: DMRC ) and completed its acqu...bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC
JERICHO, N.Y., July 30 /PRNewswire-FirstCall/ -- bioMETRX Inc., (OTC Bulletin Board: BMRX), today announced that it has completed an exclusive 15 year licensing agreement with EZ Print, LLC for the advanced remote printing technology acquired through the company's Sequiam asset purchase agreem...bioMETRX, Inc. Completes Sequiam Asset Purchase
JERICHO, N.Y., July 8 /PRNewswire-FirstCall/ -- bioMETRX Inc., (OTC Bulletin Board: BMRX), today announced that it has closed the purchase of the assets of its former competitor, Sequiam Corporation. The company also announced that it has completed the integration of those assets into the comp...Labwire Completes Its First Acquisition
HOUSTON, Dec. 11 /PRNewswire-FirstCall/ -- Labwire, Inc. (Pink Sheets: LBWR), a leading provider of employee screening solutions and canine security and surveillance services, announced today that it has completed the acquisition of Occupational Testing, Inc., an established provider of occupa...SyntheMed Completes $2.8 Million Equity Financing
ISELIN, N.J., Aug. 14 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), today announced that it has completed the initial closing of a private placement in which it received $2.8 million in gross proceeds. Robert P. Hickey, the Company's President and CEO, stated, "The proc...LIAI completes world's most comprehensive analysis on influenza virus data
Researchers from the La Jolla Institute for Allergy & Immunology (LIAI) announced today the results of a first of its kind study analyzing all published data worldwide on influenza A virus antibody and T cell epitopes. Antibody and T cell epitopes are small sites on a virus that are the target...Sandia completes depleted uranium study
Sandia National Laboratories has completed a two-year study of the potential health effects associated with accidental exposure to depleted uranium (DU) during the 1991 Gulf War. The study, "An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study," performed by Sandia scie...Cardinal Health Completes Biotech Acquisition
DUBLIN, Ohio, Aug. 3 /PRNewswire-FirstCall/ -- Cardinal Health today announced it has agreed to acquire the assets of privately held Biotech, an operator of Positron Emission Tomography (PET) cyclotrons and nuclear pharmacies in the Southwestern United States. Cardinal Health...Beckman Coulter Completes Acquisition of Olympus' Lab-Based Diagnostics Business
ORANGE COUNTY, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today the completion of the acquisition of Olympus' lab-based dia...Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
CALGARY, July 27 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) announced today that with the support of its contract manufacturer, SAFC Pharma(R), a Division of Sigma-Aldrich Corporation, it has successfully completed an initial 100-litre production run ...OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
BOTHELL, WA and VANCOUVER, July 24 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that it has completed its registered direct offering, previously announced on July 20, 2009, of 475,000 shares of its common stock to institutional investors at a price of ...GlaxoSmithKline Completes Acquisition of Stiefel
RESEARCH TRIANGLE PARK, N.C., July 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (GSK) (NYSE: GSK ) today announced that it has completed its acquisition of Stiefel Laboratories, Inc. GSK has acquired the total share capital of Stiefel for a cash consideration of $2.9 bil...Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)
CALGARY, July 20 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) announced today that it has successfully completed its lyophilization (freeze-drying) formulation development program for REOLYSIN(R). "This is the final step in the development of our manu...Nile Therapeutics, Inc. Completes $3.4 Million Private Placement
SAN FRANCISCO, July 16 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed a private placement of shares of its common stock and warrants to purchase a...Accuri Cytometers Completes $4 Million Series D Financing
ANN ARBOR, Mich., July 13 /PRNewswire/ -- Accuri Cytometers, Inc. today announced the completion of a $4 million Series D financing. The financing included current investors Fidelity Biosciences, Flagship Ventures, Baird Venture Partners and Arboretum Ventures, as well as the InvestMichigan! Prog...